NCT00847912 2021-06-11
VAKCCT
VA Office of Research and Development
Phase 4 Completed
Clinical Trials
5 trialsNCT00029900 2015-03-25
ADI-PEG in Patients With Metastatic Melanoma
FDA Office of Orphan Products Development
Phase 1 Completed
NCT00099593 2015-03-25
Immunization Against Tumor Cells in Sezary Syndrome
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00254332 2015-03-25
Effect of Denileukin Diftitox on Immune System in CTCL Patients
FDA Office of Orphan Products Development
Completed
NCT00007631 2009-01-30
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
VA Office of Research and Development
Phase 3 Completed